UNLIMITED TURBO SHORT - ABBOTT LABORATORIES Stock

Certificat

DE000PH40XK5

Delayed Deutsche Boerse AG 13:05:14 2024-05-23 EDT
3.19 EUR +0.31% Intraday chart for UNLIMITED TURBO SHORT - ABBOTT LABORATORIES
Current month+2.91%
1 month+6.35%
Date Price Change
24-05-23 3.19 +0.31%
24-05-22 3.18 -4.50%
24-05-21 3.33 +0.91%
24-05-20 3.3 +2.48%
24-05-17 3.22 +1.90%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 01:05 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH40XK
ISINDE000PH40XK5
Date issued 2021-09-13
Strike 138.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.04
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.99
Lowest since issue 0.56
Spread 0.01
Spread %0.32%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.8 USD
Average target price
125.7 USD
Spread / Average Target
+19.91%
Consensus